CRYOVALVE SG - PULMONARY HEMI-ARTERY SG SGPH00

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 06,07 report with the FDA on 2014-08-01 for CRYOVALVE SG - PULMONARY HEMI-ARTERY SG SGPH00 manufactured by Cryolife, Inc..

Event Text Entries

[4890398] The surgeon scheduled operation for (b)(6) for hypoplastic aortic arch repair/vsd closure. Surgeon chose a 45mm synergraft pulmonary hemi-artery to be used for the aortic arch repair. Staff and surgeon inspected packaging and thawed the homograft. Upon thawing and removing from pouch, it was discovered that the tissue was an aortic valve instead of the indicated pulmonary hemi-artery. Surgeon made the decision to use the aortic valve, resulting in a successful aortic arch repair. Surgeon indicated prolonged procedure time as well as homograft tissue being thicker than desired for the repair he was performing. There was no report of actual patient injury.
Patient Sequence No: 1, Text Type: D, B5


[11942087] There was no allegation of actual patient injury in abundance of caution we are reporting this as an adverse event based on the allegation of a prolonged surgery. Based the inclusion of the aortic valve, which was not intended for commercial distribution, rather than the labeled pulmonary hemiartery in the package, we are also reporting this event as a "malfunction". This investigation is currently ongoing. Any additional information will be provided in the follow-up report.
Patient Sequence No: 1, Text Type: N, H10


[37121768] The surgeon scheduled operation for (b)(6) for hypoplastic aortic arch repair/vsd closure. Surgeon chose a 45mm synergraft pulmonary hemi-artery to be used for the aortic arch repair. Staff and surgeon inspected packaging and thawed the homograft. Upon thawing and removing from pouch, it was discovered that the tissue was an aortic valve instead of the indicated pulmonary hemi-artery. Surgeon made the decision to use the aortic valve, resulting in a successful aortic arch repair. Surgeon indicated prolonged procedure time as well as homograft tissue being thicker than desired for the repair he was performing. There was no report of actual patient injury. There was no allegation of actual patient injury in abundance of caution we are reporting this as an adverse event based on the allegation of a prolonged surgery. Based the inclusion of the aortic valve, which was not intended for commercial distribution, rather than the labeled pulmonary hemiartery in the package, we are also reporting this event as a "malfunction. " the root cause for this complaint was related to the mislabeling of the allograft during the packaging process in the tissue processing laboratory. A corrective action has occurred to ensure only one allograft label is printed at a time prior to final packaging which would only allow one labeled sid card to be present during a packaging session. Also the procedure has been revised to require a member of the supervisory staff to perform the label verification prior to cryopreservation.
Patient Sequence No: 1, Text Type: N, H10


[37121769] The surgeon scheduled operation for (b)(6) for hypoplastic aortic arch repair/vsd closure. Surgeon chose a 45mm synergraft pulmonary hemi-artery to be used for the aortic arch repair. Staff and surgeon inspected packaging and thawed the homograft. Upon thawing and removing from pouch, it was discovered that the tissue was an aortic valve instead of the indicated pulmonary hemi-artery. Surgeon made the decision to use the aortic valve, resulting in a successful aortic arch repair. Surgeon indicated prolonged procedure time as well as homograft tissue being thicker than desired for the repair he was performing. There was no report of actual patient injury.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1063481-2014-00028
MDR Report Key3973804
Report Source06,07
Date Received2014-08-01
Date of Report2014-07-03
Date of Event2014-07-03
Date Mfgr Received2014-07-03
Date Added to Maude2014-08-01
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactSANDRA O'REILLY
Manufacturer Street1655 ROBERTS BLVD., NW
Manufacturer CityKENNESAW GA 30144
Manufacturer CountryUS
Manufacturer Postal30144
Manufacturer Phone7704193355
Manufacturer G1CRYOLIFE, INC.
Manufacturer Street1655 ROBERTS BLVD., NW
Manufacturer CityKENNESAW GA 30144
Manufacturer CountryUS
Manufacturer Postal Code30144
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCRYOVALVE SG - PULMONARY HEMI-ARTERY SG
Generic NameHEART ALLOGRAFT
Product CodeOHA
Date Received2014-08-01
Model NumberSGPH00
ID NumberDONOR NUMBER: 127638
OperatorPHYSICIAN
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerCRYOLIFE, INC.
Manufacturer Address1655 ROBERTS BLVD., NW KENNESAW GA 30144 US 30144


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2014-08-01

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.